PAPER Jakovcevski I, Zecevic N
SEARCH RESULTS
330712 RESULTS
PAPER Ortolano GA, Sowemimo-Coker SO, Schaffer J, Cervia JS
Prion biology in transfusion medicine: implications for lab testing.
MLO Med Lab Obs. 2005 Sep;37(9):10, 12, 14 passim; quiz 24-5. PubMed: 16265819PAPER Harris-White ME, Frautschy SA
Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):469-80. PubMed: 16266282PAPER Koch HJ, Uyanik G, Fischer-Barnicol D
Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):499-506. PubMed: 16266284PAPER Grotenhermen F
Cannabinoids.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. PubMed: 16266285PAPER Fenili D, McLaurin J
Cholesterol and apoe: a target for Alzheimer's disease therapeutics.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):553-67. PubMed: 16266288PAPER McGeer EG, McGeer PL
Abeta immunotherapy and other means to remove amyloid.
Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):569-73. PubMed: 16266289PAPER Cole GM, Lim GP, Yang F, Teter B, Begum A, Ma Q, Harris-White ME, Frautschy SA
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions.
Neurobiol Aging. 2005 Dec;26 Suppl 1:133-6. PubMed: 16266772PAPER Modi S, Moore C, Shah K,
Which late-stage Alzheimer's patients should be referred for hospice care?
J Fam Pract. 2005 Nov;54(11):984-6. PubMed: 16266605PAPER Craft S
Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation.
Neurobiol Aging. 2005 Dec;26 Suppl 1:65-9. PubMed: 16266773PAPER Syme CD, Viles JH
Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.
Biochim Biophys Acta. 2006 Feb;1764(2):246-56. PubMed: 16266835PAPER Ko M, Zou K, Minagawa H, Yu W, Gong JS, Yanagisawa K, Michikawa M
Cholesterol-mediated neurite outgrowth is differently regulated between cortical and hippocampal neurons.
J Biol Chem. 2005 Dec 30;280(52):42759-65. PubMed: 16267051PAPER Liang X, Wang Q, hand T, Wu L, Breyer RM, Montine TJ, Andreasson K
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.
J Neurosci. 2005 Nov 2;25(44):10180-7. PubMed: 16267225PAPER Perez SE, Lazarov O, Koprich JB, Chen EY, Rodriguez-Menendez V, Lipton JW, Sisodia SS, Mufson EJ
Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice.
J Neurosci. 2005 Nov 2;25(44):10220-9. PubMed: 16267229PAPER Chiba T, Yamada M, Hashimoto Y, Sato M, Sasabe J, Kita Y, Terashita K, Aiso S, Nishimoto I, Matsuoka M
Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer's disease-relevant insults in vitro and i
J Neurosci. 2005 Nov 2;25(44):10252-61. PubMed: 16267233Current Filters
- Date Range : All x